PathAI, a company that provides AI-powered technology for advancing pathology research, announced on Tuesday that it has named Pathologist and executive leader Eric Walk, MD, FCAP, as its new chief medical officer.
In the new role, Dr Walk is to manage Clinical, Regulatory, Medical Affairs and Pathology teams.
Dr Walk has held the position of chief medical & scientific officer and SVP of Medical and Scientific Affairs at Roche Tissue Diagnostics (Ventana Medical Systems). He was a member of the Roche Medical Leadership Team establishing the global medical strategy for the Diagnostics division. He has worked at Novartis Oncology in Translational Medicine and Early Clinical Development.
Dragonfly Therapeutics doses first patient in Phase 1/1b study of DF6215
Ascletis Pharma initiates ASC40 (Denifanstat) Phase III clinical trial to treat acne
Versameb names new chairman of the board
Kling Bio appoints Dr Stefano Gullà as chief scientific officer
ValiRx Plc licenses VAL401 to Ambrose Healthcare for rare disease treatments
ANGLE plc introduces Portrait+ CTC staining kit at San Antonio Breast Cancer Symposium
XNK Therapeutics announces presentation at DNB Nordic Healthcare Conference in Oslo
Syndax to discuss Axatilimab and Revumenib Data Updates at 65th ASH Annual Meeting